Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00898300
Other study ID # RTOG 0514
Secondary ID CDR0000460036
Status Completed
Phase N/A
First received May 9, 2009
Last updated November 11, 2015
Start date September 2005
Est. completion date November 2013

Study information

Verified date November 2015
Source Radiation Therapy Oncology Group
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

RATIONALE: Collecting and storing samples of tissue, blood, and saliva from patients with cancer to study in the laboratory may help the study of cancer in the future.

PURPOSE: This laboratory study is collecting and storing tissue samples from patients with head and neck cancer.


Description:

OBJECTIVES:

- Establish a tissue/specimen bank of biologic specimens collected from patients with proven or suspected head and neck cancer.

- Establish a database to link materials acquisition and pathologic and clinical information on these patients.

- Correlate clinical-pathological findings on these patients with future scientific studies using the patient database.

- Test new hypotheses as they emerge.

OUTLINE: This is a prospective, multicenter study.

Patients enrolled on active Radiation Therapy Oncology Group clinical trials undergo biopsy or surgical resection of head and neck tumors or premalignant lesions at participating institutions. Tissue and other specimens collected at the time of biopsy or surgery are submitted to the Head and Neck Cancer Tissue/Specimen Bank which acts as a central repository for processing, storing, and preserving patient specimens for translational research. Tissue samples include paraffin-embedded blocks or fresh or frozen samples of normal squamous mucosa, tumors, or premalignant lesions of the upper aerodigestive tract. Other specimens for tissue banking include serum, plasma, and lymphocytes isolated from peripheral blood, as well as samples of patient saliva. Cells obtained from tissue bank specimens may also be used to establish cell lines for future research.

PROJECTED ACCRUAL: An unlimited number of specimens will be accrued for this study.


Recruitment information / eligibility

Status Completed
Enrollment 351
Est. completion date November 2013
Est. primary completion date July 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility DISEASE CHARACTERISTICS:

- Confirmed or suspected head and neck cancer

- Primary site recurrence allowed

- Potentially eligible for or participating in an active Radiation Therapy Oncology Group treatment clinical trial

PATIENT CHARACTERISTICS:

- Zubrod performance status 0-1

PRIOR CONCURRENT THERAPY:

- See Disease Characteristics

- Concurrent radiotherapy, drug therapy, biopsy, or surgery allowed

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Intervention

Other:
biologic sample preservation procedure

Procedure:
biopsy


Locations

Country Name City State
Canada McGill Cancer Centre at McGill University Montreal Quebec
United States Hickman Cancer Center at Bixby Medical Center Adrian Michigan
United States Winship Cancer Institute of Emory University Altanta Georgia
United States American Fork Hospital American Fork Utah
United States AnMed Cancer Center Anderson South Carolina
United States Saint John's Cancer Center at Saint John's Medical Center Anderson Indiana
United States Emory Crawford Long Hospital Atlanta Georgia
United States Georgia Cancer Center for Excellence at Grady Memorial Hospital Atlanta Georgia
United States UAB Comprehensive Cancer Center Birmingham Alabama
United States Mountain States Tumor Institute at St. Luke's Regional Medical Center Boise Idaho
United States Boston University Cancer Research Center Boston Massachusetts
United States Wood County Oncology Center Bowling Green Ohio
United States Roswell Park Cancer Institute Buffalo New York
United States Sandra L. Maxwell Cancer Center Cedar City Utah
United States Presbyterian Cancer Center at Presbyterian Hospital Charlotte North Carolina
United States John H. Stroger, Jr. Hospital of Cook County Chicago Illinois
United States Rush University Medical Center Chicago Illinois
United States North Coast Cancer Care - Clyde Clyde Ohio
United States Penrose Cancer Center at Penrose Hospital Colorado Springs Colorado
United States Barbara Ann Karmanos Cancer Institute Detroit Michigan
United States Good Samaritan Cancer Care Center at Advocate Good Samaritan Hospital Downers Grove Illinois
United States Hematology Oncology Center Elyria Ohio
United States Fredericksburg Oncology, Incorporated Fredericksburg Virginia
United States Wayne Memorial Hospital, Incorporated Goldsboro North Carolina
United States Wayne Radiation Oncology Goldsboro North Carolina
United States Ingalls Cancer Care Center at Ingalls Memorial Hospital Harvey Illinois
United States M. D. Anderson Cancer Center at University of Texas Houston Texas
United States St. Vincent Oncology Center Indianapolis Indiana
United States Borgess Medical Center Kalamazoo Michigan
United States Bronson Methodist Hospital Kalamazoo Michigan
United States West Michigan Cancer Center Kalamazoo Michigan
United States CCOP - Kansas City Kansas City Missouri
United States North Kansas City Hospital Kansas City Missouri
United States Parvin Radiation Oncology Kansas City Missouri
United States Research Medical Center Kansas City Missouri
United States Saint Luke's Cancer Institute at Saint Luke's Hospital Kansas City Missouri
United States St. Joseph Medical Center Kansas City Missouri
United States Truman Medical Center - Hospital Hill Kansas City Missouri
United States Good Samaritan Cancer Center at Good Samaritan Hospital Kearney Nebraska
United States Kingsbury Center for Cancer Care at Cheshire Medical Center Keene New Hampshire
United States Haematology-Oncology Associates of Ohio and Michigan, PC Lambertville Michigan
United States Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center Lebanon New Hampshire
United States Lima Memorial Hospital Lima Ohio
United States Monmouth Medical Center Long Branch New Jersey
United States James Graham Brown Cancer Center at University of Louisville Louisville Kentucky
United States University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison Wisconsin
United States Northwest Ohio Oncology Center Maumee Ohio
United States St. Luke's Hospital Maumee Ohio
United States Medical College of Wisconsin Cancer Center Milwaukee Wisconsin
United States Providence Milwaukie Hospital Milwaukie Oregon
United States Community Cancer Center of Monroe Monroe Michigan
United States Mercy Memorial Hospital - Monroe Monroe Michigan
United States Cancer Center at Ball Memorial Hospital Muncie Indiana
United States Jon and Karen Huntsman Cancer Center at Intermountain Medical Center Murray Utah
United States Saint Peter's University Hospital New Brunswick New Jersey
United States Beth Israel Medical Center - Petrie Division New York New York
United States Fisher-Titus Medical Center Norwalk Ohio
United States Val and Ann Browning Cancer Center at McKay-Dee Hospital Center Ogden Utah
United States Oklahoma University Cancer Institute Oklahoma City Oklahoma
United States Methodist Estabrook Cancer Center Omaha Nebraska
United States St. Charles Mercy Hospital Oregon Ohio
United States Toledo Clinic - Oregon Oregon Ohio
United States M.D. Anderson Cancer Center at Orlando Orlando Florida
United States Menorah Medical Center Overland Park Kansas
United States Advocate Lutheran General Cancer Care Center Park Ridge Illinois
United States Methodist Medical Center of Illinois Peoria Illinois
United States Albert Einstein Cancer Center Philadelphia Pennsylvania
United States Fox Chase Cancer Center - Philadelphia Philadelphia Pennsylvania
United States Adventist Medical Center Portland Oregon
United States CCOP - Columbia River Oncology Program Portland Oregon
United States Providence Cancer Center at Providence Portland Medical Center Portland Oregon
United States Providence St. Vincent Medical Center Portland Oregon
United States Veterans Affairs Medical Center - Portland Portland Oregon
United States Utah Valley Regional Medical Center - Provo Provo Utah
United States Renown Institute for Cancer at Renown Regional Medical Center Reno Nevada
United States Mayo Clinic Cancer Center Rochester Minnesota
United States Rutherford Hospital Rutherfordton North Carolina
United States University of California Davis Cancer Center Sacramento California
United States Dixie Regional Medical Center - East Campus Saint George Utah
United States Norris Cotton Cancer Center - North Saint Johnsbury Vermont
United States Heartland Regional Medical Center Saint Joseph Missouri
United States LDS Hospital Salt Lake City Utah
United States Utah Cancer Specialists at UCS Cancer Center Salt Lake City Utah
United States North Coast Cancer Care, Incorporated Sandusky Ohio
United States Shawnee Mission Medical Center Shawnee Mission Kansas
United States CCOP - Upstate Carolina Spartanburg South Carolina
United States Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg South Carolina
United States Cancer Institute at St. John's Hospital Springfield Illinois
United States Flower Hospital Cancer Center Sylvania Ohio
United States Mercy Hospital of Tiffin Tiffin Ohio
United States CCOP - Toledo Community Hospital Toledo Ohio
United States Medical University of Ohio Cancer Center Toledo Ohio
United States St. Anne Mercy Hospital Toledo Ohio
United States St. Vincent Mercy Medical Center Toledo Ohio
United States Toledo Clinic, Incorporated - Main Clinic Toledo Ohio
United States Toledo Hospital Toledo Ohio
United States Southwest Washington Medical Center Cancer Center Vancouver Washington
United States Fulton County Health Center Wauseon Ohio

Sponsors (2)

Lead Sponsor Collaborator
Radiation Therapy Oncology Group National Cancer Institute (NCI)

Countries where clinical trial is conducted

United States,  Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Establishment of a Head and Neck Cancer Tissue/Specimen Bank From the start of enrollment to the end of enrollment; enrollment closed at 351 patients No
See also
  Status Clinical Trial Phase
Recruiting NCT05808920 - The RESCUE Study: Survival and Functional Outcomes Following Salvage Surgery for RESidual or reCurrent sqUamous cEll Carcinoma of the Head and Neck
Completed NCT02526017 - Study of Cabiralizumab in Combination With Nivolumab in Patients With Selected Advanced Cancers Phase 1
Active, not recruiting NCT05060432 - Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT03997643 - Preservation of Swallowing in Respected Oral Cavity Squamous Cell Carcinoma: Examining Radiation Volume Effects (PRESERVE): A Randomized Trial Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Recruiting NCT04700475 - Effect of Low Level Laser Therapy on Prevention of Radiotherapy Induced Xerostomia in Cancer Patients. N/A
Withdrawn NCT04058145 - AMD3100 Plus Pembrolizumab in Immune Checkpoint Blockade Refractory Head and Neck Squamous Cell Carcinoma Phase 2
Completed NCT02572869 - Functional and Aesthetic Outcomes After Mandible Reconstruction With Fibula Osteomyocutaneous Free Flaps
Active, not recruiting NCT04474470 - A Study to Evaluate NT219 Alone and in Combination With ERBITUX® (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer Phase 1/Phase 2
Withdrawn NCT05073809 - Photoacoustic Imaging of Head and Neck Tumours
Active, not recruiting NCT04383210 - Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors Phase 2
Active, not recruiting NCT03651570 - Randomized Controlled Trial of a E-intervention to Help Patients Newly Diagnosed With Cancer Cope Better: Pilot Study N/A
Recruiting NCT04930432 - Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors Phase 1/Phase 2
Recruiting NCT06016699 - Immunological Function After Radiation With Either Proton or Photon Therapy
Terminated NCT03843554 - Commensal Oral Microbiota in Head and Neck Cancer N/A
Recruiting NCT05915572 - Mulligan Technique on Shoulder Dysfunction N/A
Completed NCT05897983 - Tens and Rocabado Exercises on TMJ Dysfunction N/A
Not yet recruiting NCT06289049 - Heavy Strength Training in Head and Neck Cancer Survivors Phase 2
Withdrawn NCT05263648 - Virtual Reality Software to Reduce Stress in Cancer Patients N/A
Withdrawn NCT03238638 - A Study of Epacadostat + Pembrolizumab in Head and Neck Cancer Patients, Who Failed Prior PD-1/PD-L1 Therapy Phase 2